Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation-Reference-Cited by-同舟云学术

Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation

Published:2023-05-15 Issue:1 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Bei Zhu-Chun¹^ORCID,Yu Huanhuan¹²,Wang Hong¹,Li Qingyun¹³,Wang Baogang¹,Zhang Dongna¹,Xu Likun¹,Zhao Liangliang¹,Dong Shuwei²,Song Yabin¹

Affiliation:

1. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People’s Republic of China

2. The Affiliated AnNing First Hospital, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, People’s Republic of China

3. Clinical Laboratory, Chinese People’s Liberation Army, Taiyuan, People’s Republic of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2211688

Reference60 articles.

1. Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective

2. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

3. Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

4. Hu Y Lewandowski EM Tan H et al. Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir. bioRxiv [Preprint]. 2022:2022.06.28.497978.

5. Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity;Scientific Reports;2024-09-05

2. In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-08-20

3. A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro inhibitors;2024-05-23

4. Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019;Viruses;2024-04-30

5. Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection;European Journal of Medicinal Chemistry;2024-01